About
Fullerene carbon nanotubes as delivery agents for cancer therapeutics
Areas of Focus
Categories
Drug Delivery & FormulationSan Diego & Southern California
Team (10)
Andrew Benton
Andrew Benton
Ensysce Biosciences
team_member
Dave Humphrey
Dave Humphrey
Ensysce Biosciences
team_member
Geoff Birkett
Geoff Birkett
Ensysce Biosciences
team_member
Jeffrey Millard
Jeffrey Millard, PhD
Ensysce Biosciences
team_member
Jeffrey MillardPhD
Jeffrey MillardPhD
Ensysce Biosciences
team_member
Lee Rauch
Lee Rauch
Ensysce Biosciences
team_member
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
701
By Phase
PHASE3: 1PHASE1: 7PHASE2: 1
By Status
COMPLETED: 7NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06602271Lead Sponsor
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
PHASE3Not yet recruiting
300 participants
Started: Mar 31, 2025 · Completed: Apr 30, 2026
NCT06500793Lead Sponsor
Single and Multi-Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)
PHASE1Recruiting
50 participants
Started: Nov 24, 2024 · Completed: Mar 27, 2026
NCT06629402Lead Sponsor
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
PHASE2Completed
16 participants
Started: Oct 5, 2023 · Completed: Nov 15, 2023
NCT05571345Lead Sponsor
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)
PHASE1Completed
32 participants
Started: Oct 5, 2022 · Completed: Dec 28, 2022
NCT05567354Lead Sponsor
A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)
PHASE1Completed
27 participants
Started: Jun 10, 2022 · Completed: Aug 31, 2022
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...